Open Access

Analysis of clinical characteristics of macrophage capping protein (CAPG) gene expressed in glioma based on TCGA data and clinical experiments

  • Authors:
    • Qiang Fu
    • Mahati Shaya
    • Shaoshan Li
    • Yalikun Kugeluke
    • Yisireyili Dilimulati
    • Bo Liu
    • Qingjiu Zhou
  • View Affiliations

  • Published online on: May 23, 2019     https://doi.org/10.3892/ol.2019.10396
  • Copyright: © Fu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Macrophage capping protein (CAPG) genes were investigated based on The Cancer Genome Atlas (TCGA) database and clinical experiments. Glioblastoma (GBM) genes expression profiling chip of 529 disease samples and 10 normal samples selected from TCGA database were used for analysis, 25 brain glioma tissue samples and 15 normal brain tissues were collected in the Department of Neurosurgery of the First Affiliated Hospital of Xinjiang Medical University in China from 2016 to 2017 to analyze CAPG genes. TCGA results showed that the expression level of CAPG genes in GBM was higher than that in normal tissues, and the expression level of men, aged over 46 years and high grade gliomas in pathological stages was higher than that of women, aged ≤46 and low grade gliomas in pathological stages, and the survival time of high expression was shorter than that of low expression. The expression level of CAPG in glioma tissues was higher than that in normal tissues, and the expression level of CAPG in males was higher than that in females, as males had lymphatic transfer and low differentiation compared with females, but the expression level was not related to age. Survival analysis showed that higher expression level indicated shorter survival time, they were positively correlated. The expression of CAPG in glioma is high, and it is highly expressed with the severity of the disease, and it is also obviously related to the prognosis. Therefore, CAPG could be used as a biomarker for pathological grade and prognosis in glioma. However, the related studies are not consistent on the expression of different sex and ages, so further study is needed.

Related Articles

Journal Cover

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Fu, Q., Shaya, M., Li, S., Kugeluke, Y., Dilimulati, Y., Liu, B., & Zhou, Q. (1899). Analysis of clinical characteristics of macrophage capping protein (CAPG) gene expressed in glioma based on TCGA data and clinical experiments. Oncology Letters, 0, 0-0. https://doi.org/10.3892/ol.2019.10396
MLA
Fu, Q., Shaya, M., Li, S., Kugeluke, Y., Dilimulati, Y., Liu, B., Zhou, Q."Analysis of clinical characteristics of macrophage capping protein (CAPG) gene expressed in glioma based on TCGA data and clinical experiments". Oncology Letters 0.0 (1899): 0-0.
Chicago
Fu, Q., Shaya, M., Li, S., Kugeluke, Y., Dilimulati, Y., Liu, B., Zhou, Q."Analysis of clinical characteristics of macrophage capping protein (CAPG) gene expressed in glioma based on TCGA data and clinical experiments". Oncology Letters 0, no. 0 (1899): 0-0. https://doi.org/10.3892/ol.2019.10396